EC Number | Application | Comment | Organism |
---|---|---|---|
3.4.21.95 | medicine | small peptides derived from factor V activator destabilize the beta-amyloid aggregate. Peptide CTNIF and a mixture of six peptides are most potent in converting the aggregates to the monomeric state and thus, preventing cytotoxicity in SH-SY5Y human neuroblastoma cells. Some of the peptides are stable in blood for 24 h | Daboia russelii |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
3.4.21.95 | Daboia russelii | - |
- |
- |
EC Number | Purification (Comment) | Organism |
---|---|---|
3.4.21.95 | - |
Daboia russelii |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
3.4.21.95 | venom | - |
Daboia russelii | - |
EC Number | General Information | Comment | Organism |
---|---|---|---|
3.4.21.95 | physiological function | small peptides derived from factor V activator destabilize the beta-amyloid aggregate. Factor V activator-mediated proteolysis is not involved. Peptide CTNIF and a mixture of six peptides are most potent in converting the aggregates to the monomeric state and thus, preventing cytotoxicity in SH-SY5Y human neuroblastoma cells | Daboia russelii |